http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20170076956-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d98762490c9bfd1551fefe55f49ea2c |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-306 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-16 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-18 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-41 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-16 |
| filingDate | 2015-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66f52a6550a8844e99b91dfdda5e5a03 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c532d5cb43d096e9a5a655acdc3cfb7f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_333a15dc102d86ab872a1539090e0325 |
| publicationDate | 2017-07-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-20170076956-A |
| titleOfInvention | A composition for prevention or treatment of bone disease comprising haptoglobin |
| abstract | The present invention relates to a composition for preventing or treating osteoporosis comprising hogglobulin as an active ingredient. More specifically, the present invention relates to a composition for preventing or treating osteoporosis by inhibiting osteoclast differentiation by increasing expression of IFN beta A composition for preventing or treating osteopathy which comprises as an active ingredient a combination of togoglobin having an effect of inhibiting bone loss caused by excessive differentiation and activity of osteoclasts due to bone metastasis of cancer cells to prevent bone loss, To a subject, and a food composition for preventing or improving bone diseases. The present invention provides a method for inhibiting osteoclast differentiation by inhibiting the differentiation of osteoclast by inhibiting the differentiation of osteoclast, osteoclast, osteoclast, osteoclast, osteoclast The present invention can be used not only as a bone loss disease caused by bone metastasis of cancer cells but also as a therapeutic agent for various bone metabolic diseases since it has an effect of preventing bone loss by remarkably suppressing bone loss caused by excessive differentiation and activity. |
| priorityDate | 2015-12-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 444.